Sign in to view content

Brolucizumab: Will it Make a Differance

Andrew P. Schachat, MD

Video
Published 2018

Related

Efficacy and Durability of Brolucizumab in Patients Being Transitioned From Prior Anti-VEGF Therapy
Scott D Walter, MD, MSc, FASRS
Annual Meeting Talks
2021
Ethics in Retina: A Discussion on the Ethical Considerations in Industry Relationships and Informed Consent
Nancy M. Holekamp, MD, FASRS
J. Michael Jumper, MD, FASRS
Paul Chan
Adrienne W. Scott, MD, FASRS
Webinars and Journal Clubs
2017
Biosimilars: What Can Retina Learn from Oncology?
Kathy W Oubre, MS
Updates from the Field
2022

Category: AMD-Neovascular

See more